The FDA approved a new treatment for adults with endogenous hypercortisolemia related to Cushing's syndrome, Xeris Biopharma announced late last week. The oral drug levoketoconazole (Recorlev) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback